Effects of rasagiline, its metabolite aminoindan and selegiline on glutamate receptor mediated signalling in the rat hippocampus slice in vitro

Overview of attention for article published in BMC Pharmacology, February 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 28 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

AN ORODISPERSIBLE PHARMACEUTICAL SOLID DOSAGE FORM OF RASAGILINE

Application WO-2022162612-A1

World Intellectual Property Organisation (WIPO)

AN ORODISPERSIBLE PHARMACEUTICAL SOLID DOSAGE FORM OF RASAGILINE

Application EP-4035654-A1

European Patent Office

MESEMBRENOL AND/OR MESEMBRANOL FOR PROPHYLAXIS AND TREATMENT OF PATIENTS SUFFERING FROM…

Application WO-2019021196-A1

World Intellectual Property Organisation (WIPO)

Herbal extracts from the evening primrose (Oenothera biennis) for the treatment of…

Application EP-2703002-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.